Bordetella parapertussis PagP mediates the addition of two palmitates to the lipopolysaccharide lipid A

Journal of Bacteriology

Volumn 197, Issue 3, 2015, Pages 572-580

  Hittle, L E ^a   Jones, J W ^a   Hajjar, A M ^b   Ernst, R K ^a   Preston, A ^c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BORDETELLA BRONCHISEPTICA PAGP; LIPID A; PALMITIC ACID DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ACYLTRANSFERASE;

ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BORDETELLA PARAPERTUSSIS; HUMAN; LIPOGENESIS; MASS SPECTROMETRY; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE;

BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; BORDETELLA PARAPERTUSSIS; MURINAE;

ACYLTRANSFERASES; BORDETELLA PARAPERTUSSIS; DNA MUTATIONAL ANALYSIS; LIPID A; MASS SPECTROMETRY; PALMITATES;

EID: 84920771792     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02236-14     Document Type: Article

References (34)

1. Cherry JD. 1992. Pertussis-the trials and tribulations of old and new pertussis vaccines. Vaccine 10:1033-1038. http://dx.doi.org/10.1016/0264-410X(92)90113-X.
2. Cherry JD. 1996. Historical review of pertussis and the classical vaccine. J Infect Dis 174(Suppl 3):S259-S263.
3. Heininger U, Stehr K, Schmittgrohe S, Lorenz C, Rost R, Christenson PD, Uberall M, Cherry JD. 1994. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 13:306-309. http://dx.doi.org/10.1097/00006454-199404000-00011.
4. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. 1996. Prevalence and incidence of adult pertussis in an urban population. JAMA 275:1672-1674. http://dx.doi.org/10.1001/jama.1996.03530450062034.
5. Pichichero ME, Treanor J. 1997. Economic impact of pertussis. Arch Pediatr Adolesc Med 151:35-40. http://dx.doi.org/10.1001/archpedi.1997.02170380039006.
6. Watanabe M, Nagai M. 2004. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2:447-454. http://dx.doi.org/10.1586/14787210.2.3.447.
7. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326-382. http://dx.doi.org/10.1128/CMR.18.2.326-382.2005.
8. Zhang X, Rodriguez ME, Harvill ET. 2009. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One 4:e6989. http://dx.doi.org/10.1371/journal.pone.0006989.
9. Luderitz O, Galanos C, Lehmann V, Nurminen J, Rietschel ET, Rosenfelder G, Simon M, Westphal O. 1973. Lipid A: chemical structure and biological activity. J Infect Dis 128:S17-S29. http://dx.doi.org/10.1093/infdis/128.Supplement_1.S17.
10. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511. http://dx.doi.org/10.1038/nri1391.
11. Caroff M, Aussel L, Zarrouk H, Martin A, Richards JC, Therisod H, Perry MB, Karibian D. 2001. Structural variability and originality of the Bordetella endotoxins. Innate Immun 7:63-68. http://dx.doi.org/10.1177/09680519010070011101.
12. MacArthur I, Jones JW, Goodlett DR, Ernst RK, Preston A. 2011. Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis. J Bacteriol 193:4726-4735. http://dx.doi.org/10.1128/JB.01502-10.
13. Preston A, Maxim E, Toland E, Pishko EJ, Harvill ET, Caroff M, Maskell DJ. 2003. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol 48:725-736. http://dx.doi.org/10.1046/j.1365-2958.2003.03484.x.
14. Cotter PA, Miller JF. 2001. Bordetella, p 619-674. In Groisman E (ed), Principles of bacterial pathogenesis. Academic Press, San Diego, CA.
15. Pilione MR, Pishko EJ, Preston A, Maskell DJ, Harvill ET. 2004. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun 72:2837-2842. http://dx.doi.org/10.1128/IAI.72.5.2837-2842.2004.
16. El Hamidi A, Novikov A, Karibian D, Perry MB, Caroff M. 2009. Structural characterization of Bordetella parapertussis lipid A. J Lipid Res 50:854-859. http://dx.doi.org/10.1194/jlr.M800454-JLR200.
17. Simon R, Priefer U, Pühler A. 1982. A broad hostrange mobilisation system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Biotechnology 1:784-791.
18. Schweizer HP, Hoang TT. 1995. An improved system for gene replacement and XylE fusion analysis in Pseudomonas aeruginosa. Gene 158:15-22. http://dx.doi.org/10.1016/0378-1119(95)00055-B.
19. Kovach ME, Phillips RW, Elzer PH, Roop RM, II, Peterson KM. 1994. pBBR1MCS: a broad-host-range cloning vector. Biotechniques 16:800-801.
20. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect Immun 72:5041-5051. http://dx.doi.org/10.1128/IAI.72.9.5041-5051.2004.
21. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Preston A, Allen AG, Cadisch J, Thomas R, Stevens K, Churcher CM, Badcock KL, Parkhill J, Barrell B, Maskell DJ. 1999. Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun 67:3763-3767.
23. Preston A, Mandrell RE, Gibson BW, Apicella MA. 1996. The lipooligosaccharides of pathogenic Gram-negative bacteria. Crit Rev Microbiol 22:139-180. http://dx.doi.org/10.3109/10408419609106458.
24. Westphal O, Jann K. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5:83-91.
25. Fischer W, Koch HU, Haas R. 1983. Improved preparation of lipoteichoic acids. Eur J Biochem 133:523-530. http://dx.doi.org/10.1111/j.1432-1033.1983.tb07495.x.
26. Caroff M, Tacken A, Szabo L. 1988. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. Carbohydr Res 175:273-282. http://dx.doi.org/10.1016/0008-6215(88)84149-1.
27. King JD, Vinogradov E, Preston A, Li J, Maskell DJ. 2009. Postassembly modification of Bordetella bronchiseptica O polysaccharide by a novel periplasmic enzyme encoded by wbmE. J Biol Chem 284:1474-1483. http://dx.doi.org/10.1074/jbc.M807729200.
28. Jones JW, Shaffer SA, Ernst RK, Goodlett DR, Turecek F. 2008. Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approach. Proc Natl Acad Sci USA 105:12742-12747. http://dx.doi.org/10.1073/pnas.0800445105.
29. Domon B, Costello CE. 1988. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj J 5:397-409. http://dx.doi.org/10.1007/BF01049915.
30. Darveau RP, Blake J, Seachord CL, Cosand WL, Cunningham MD, Cassiano-Clough L, Maloney G. 1992. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest 90:447-455. http://dx.doi.org/10.1172/JCI115880.
31. Sweet CR, Preston A, Toland E, Ramirez SM, Cotter RJ, Maskell DJ, Raetz CR. 2002. Relaxed acyl chain specificity of Bordetella UDP-Nacetylglucosamine acyltransferases. J Biol Chem 277:18281-18290. http://dx.doi.org/10.1074/jbc.M201057200.
32. Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198. http://dx.doi.org/10.1016/S0092-8674(00)81750-X.
33. Wolfe DN, Buboltz AM, Harvill ET. 2009. Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One 4:e4280. http://dx.doi.org/10.1371/journal.pone.0004280.
34. MacArthur I, Mann PB, Harvill ET, Preston A. 2007. IEIIS Meeting minireview. Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res 13:243-247. http://dx.doi.org/10.1177/0968051907082609.